Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations-Reference-Cited by-同舟云学术

Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations

Published:2021-02-21 Issue:1 Volume:149 Page:119-126
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Amin Nadia Emad Lotfi¹^ORCID,Hansen Torben Frøstrup¹^ORCID,Fernebro Eva²,Ploen John¹,Eberhard Jakob³,Lindebjerg Jan¹,Jensen Lars Henrik¹^ORCID

Affiliation:

1. Department of Oncology, Vejle Hospital University of Southern Denmark Vejle Denmark

2. Department of Oncology Växjö Hospital Växjö Sweden

3. Department of Clinical Sciences, Division of Oncology Lund University Lund Sweden

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33509

Reference34 articles.

1. Medical treatment for cholangiocarcinoma

2. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma

3. Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma

4. Update on the Diagnosis and Treatment of Cholangiocarcinoma

5. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma;Cancers;2024-04-26

2. Emerging Therapies in Management of Cholangiocarcinoma;Cancers;2024-01-31

3. Promising Outcomes of Modified ALPPS for Staged Hepatectomy in Cholangiocarcinoma;Cancers;2023-11-28

4. Intrahepatic cholangiocarcinoma: Evolving role of neoadjuvant and targeted therapy;Annals of Hepato-Biliary-Pancreatic Surgery;2023-02-24

5. Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer;Cancers;2023-02-07